TriSalus Life Sciences (TLSI) Depreciation & Amortization (CF) (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Depreciation & Amortization (CF) of $135000.0 for Q1 2026, down 21.51% year-over-year from $172000.0 in Q1 2025, and up 7.14% quarter-over-quarter from $126000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $135000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 21.51% year-over-year to $135000.0; the TTM figure through Mar 2026 stood at $589000.0 (down 20.51% YoY), while the FY2025 annual figure was $626000.0, down 15.86% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $135000.0, up from $126000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $194000.0 in Q4 2023, with the low at -$54000.0 in Q4 2022.
- The 5-year median for Depreciation & Amortization (CF) is $168500.0 (2025), against an average of $152500.0.
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) jumped 459.26% in 2023, then slumped 34.72% in 2025.
- TriSalus Life Sciences' Depreciation & Amortization (CF) stood at -$54000.0 in 2022, then surged by 459.26% to $194000.0 in 2023, then retreated by 0.52% to $193000.0 in 2024, then plunged by 34.72% to $126000.0 in 2025, then increased by 7.14% to $135000.0 in 2026.
- Business Quant data shows TLSI's Depreciation & Amortization (CF) at $135000.0 in Q1 2026, $126000.0 in Q4 2025, and $163000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 123.80 Mn |
| 10 | TriSalus Life Sciences | 306.64 Mn | 260.35 Mn | 9.90 Mn | 136,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 136,000.00 |
| Jun 30, 2026 | 136,000.00 |
| Mar 31, 2026 | 135,000.00 |
| Mar 31, 2026 | 135,000.00 |
| Dec 31, 2025 | 126,000.00 |
| Dec 31, 2025 | 126,000.00 |
| Sep 30, 2025 | 163,000.00 |
| Sep 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Dec 31, 2024 | 193,000.00 |
| Sep 30, 2024 | 182,000.00 |
| Sep 30, 2024 | 182,000.00 |
| Jun 30, 2024 | 194,000.00 |
| Jun 30, 2024 | 194,000.00 |
| Mar 31, 2024 | 175,000.00 |
| Mar 31, 2024 | 175,000.00 |